Latest Content

Through pharmacists’ statewide billing capabilities, researchers explore how educational support impacts community pharmacies’ medical billing.

New policies urge pharmacists to identify disinformation and seek legal protection against AI-generated impersonation.

Detailed results show the investigational islatravir/lenacapavir combination sustained virologic suppression as a potential once weekly HIV treatment.

Through the lens of pharmacist satisfaction, researchers assess the implementation and real-world use of medication alert systems.

In part 2, Richard Dion, PharmD, addresses some of the persistent challenges among hospital pharmacies and their pain management models, offering some expert solutions to move forward.

This episode explores PBMs’ copay collection discrepancies and how improper documentation can be the downfall for pharmacy business.

Pharmacists and other clinicians counseling postpartum patients may find more success with meal-timing strategies that require minimal disruption to routines.

A new report on glucagon-like peptide-1 receptor agonists for obesity finds real clinical value alongside budget impact that already exceeds the review's own threshold.

Immunology expert Paul Licciardi, PhD, weighs in on the current state of recommended pneumococcal vaccines and what is on the horizon in the developmental stage.

In part 2, Paul Licciardi, PhD, dives into the evolving need for updated pneumococcal vaccine recommendations and how pharmacists can keep their patients informed.

A secret shopper study finds most are still compounding semaglutide and tirzepatide with additives, often through suppliers lacking sterile compounding licenses.

Richard Dion, PharmD, joins to discuss the growing prominence of opioid stewardship and where the pharmacist can assist in patient programming.

Analyzing nearly a decade of pharmaceutical interventions in community pharmacies, researchers reveal the role pharmacists play in self-medication.

Bivalent mRNA and protein-based fourth doses produce comparable protection against Omicron JN.1 infection over 12 months.

In part 1 of our interview with Paul Licciardi, PhD, he addresses the lowered pneumococcal vaccination age as well as the adult population’s overall relationship with immunization.

Pharmacist credentialing unlocks payer contracts and boosts reimbursement and can help avoid risky third-party billing as clinical services expand.

With calls to expand access across the health care ecosystem, researchers explore pharmacists' perceptions regarding independent prescribing.

A rapidly growing multistate cyclosporiasis outbreak has pushed national case counts to nearly 7000.

With the Medicare GLP-1 Bridge Program just 2 weeks old, a drug market expert shared their thoughts on what the initiative may mean for pharmacists and their patients.

Nine pharmacy organizations state that the revised charter overemphasizes vaccine risk and could delay recommendations pharmacists rely on for scope of practice and insurance coverage.

Among adult patients who have reported a case of invasive pneumococcal disease, researchers address the association of risk factors and recurrent disease.

Lipfendra (enlicitide) showed placebo-adjusted low-density lipoprotein cholesterol reductions of more than 50% in 2 phase 3 trials.

Emerging data show glucagon-like peptide-1 receptor agonists may raise the risk of certain autoimmune diseases compared with other diabetes drugs.

In this episode, Natalie DiPietro Mager, PharmD, PhD, talks with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, about how pharmacists can address cannabis use in women during adolescence, reproductive years, and older adulthood.

Investigators test 3 repurposed drugs alongside specialist care, finding small, transient fatigue improvements for long COVID fatigue.

With GLP-1 questions creating confusion for Medicare patients, pharmacists are becoming the trusted frontline resource, and the stakes for getting it right have never been higher.

New research links a national surge in poison control calls involving semaglutide to preventable dosing mistakes rather than intentional misuse.

With the goal of optimizing long-term weight-loss treatment, researchers gather insights regarding the lived experiences of glucagon-like peptide-1 users.

Drug shortages drop in 2025, yet long-lasting sterile injectable gaps, rising discontinuations, and fragile supply chains reshape pharmacy work.

In an assessment of pharmacy closures, researchers hypothesize underserved neighborhoods would be the most burdened locations across the country.

Subcutaneous lecanemab-irmb can now be self-administered or given by a caregiver from the first dose, eliminating the requirement for an initial in-clinic intravenous infusion.